Endothelin antagonists and the quest for a new therapeutic option in resistant hypertension. Dechend R, Delles C. Lancet 2022 Nov 4. pii: S0140-6736(22)02181.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dechend R, Delles C. Endothelin antagonists and the quest for a new therapeutic option in resistant hypertension. Lancet 2022 Nov 4. pii: S0140-6736(22)02181.
PMID: 36356630